HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA
Clinical trials for HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA explained in plain language.
Never miss a new study
Get alerted when new HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA trials appear
Sign up with your email to follow new studies for HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibiotic OMN6 tested against tough lung infection
Disease control Recruiting nowThis phase 2a trial tests an experimental antibiotic called OMN6 in 54 adults with hospital-acquired or ventilator-associated pneumonia caused by Acinetobacter baumannii. Participants receive either OMN6 or a placebo, plus standard antibiotics, for one day. The main goal is to ch…
Matched conditions: HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA
Phase: PHASE2 • Sponsor: Omnix Medical Ltd • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New antibiotic combo takes on deadly hospital pneumonia
Disease control Recruiting nowThis phase 3 trial tests a new antibiotic combination (meropenem and pralurbactam) against an existing one (ceftazidime and avibactam) for treating hospital-acquired and ventilator-associated bacterial pneumonia. About 420 adults will participate, and the main goal is to see if t…
Matched conditions: HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC